Infectomics of Chikungunya Virus: Roles Played by Host Factors.

Area of Science:

• Virology
• Immunology
• Epidemiology

Background:

• Chikungunya virus (CHIKV) causes debilitating joint pain and spreads via Aedes mosquitoes, with recent global expansion.
• Current treatments for CHIKV infection are lacking, and the newly approved vaccine has associated risks requiring further study.
• Understanding CHIKV's interaction with host factors is crucial for developing effective therapeutics.

Purpose of the Study:

• To review host factors as potential therapeutic targets for CHIKV infection.
• To explore strategies for enhancing the host immune response against CHIKV.
• To highlight the need for novel treatment approaches beyond viral protein inhibition.

Main Methods:

• Literature review of CHIKV pathogenesis and host-pathogen interactions.
• Analysis of current therapeutic strategies and vaccine development.
• Exploration of host-directed therapy and immunomodulatory approaches.

Main Results:

• CHIKV exploits specific host factors, presenting potential targets for drug development.
• Host-directed therapies offer an alternative to targeting viral proteins, potentially overcoming resistance.
• Enhancing the host immune response is a promising avenue for CHIKV treatment.

Conclusions:

• Targeting host-pathogen interactions is a key emerging strategy for CHIKV therapeutics.
• Further research into host immune responses is essential for developing effective treatments.
• Novel therapeutic strategies are urgently needed to combat the growing global threat of CHIKV.